Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Kansai Hepato-Biliary Oncology Group, Osaka, Japan.
Cancer Rep (Hoboken). 2021 Apr;4(2):e1323. doi: 10.1002/cnr2.1323. Epub 2020 Dec 6.
Only few studies in literature have analyzed the clinical effects of peritoneal lavage status in biliary tract cancers.
We aimed to assess the effect of cytology-positive peritoneal lavage on survival for patients with biliary tract cancer who underwent curative resection.
The KHBO1701 study was a multi-institutional retrospective study that assessed the clinical effects of peritoneal lavage cytology in biliary tract cancers. Using clinicopathological data from 11 Japanese institutions, we compared long-term outcomes between patients with cytology-positive and cytology-negative peritoneal lavage.
Of 169 patients who underwent curative resection, 164 were cytology-negative, and five were cytology-positive. The incidence of portal invasion and preoperative carbohydrate antigen 19-9 levels were higher in the cytology-positive group than in the cytology-negative group. The incidence of peritoneal metastatic recurrence was also higher, and overall survival tended to be worse in the cytology-positive group. In contrast, recurrence-free survival was similar between the cytology-negative and cytology-positive groups.
The positive status of peritoneal lavage cytology could moderately affect the survival of patients with biliary tract cancers. Given that surgical resection is the only curative treatment option, it may be acceptable to resect biliary tract cancers without other non-curative factors, regardless of peritoneal lavage cytology status.
仅有少数文献研究分析了胆道癌患者腹腔灌洗状况的临床效果。
我们旨在评估细胞学阳性的腹腔灌洗对接受根治性切除术的胆道癌患者生存的影响。
KHBO1701 研究是一项多机构回顾性研究,评估了腹腔灌洗细胞学在胆道癌中的临床效果。我们利用来自 11 家日本机构的临床病理数据,比较了细胞学阳性和细胞学阴性腹腔灌洗患者的长期预后。
在接受根治性切除术的 169 例患者中,164 例为细胞学阴性,5 例为细胞学阳性。细胞学阳性组的门静脉侵犯和术前癌抗原 19-9 水平的发生率高于细胞学阴性组。细胞学阳性组的腹膜转移复发发生率也较高,总生存时间较差。相比之下,细胞学阴性组和细胞学阳性组的无复发生存率相似。
腹腔灌洗细胞学阳性状态可能会适度影响胆道癌患者的生存。鉴于手术切除是唯一的根治性治疗选择,对于没有其他非根治性因素的胆道癌患者,可能可以接受切除,而无需考虑腹腔灌洗细胞学状态。